Friday, February 10, 2012
The CEO of The Susan G. Komen Foundation nonprofit has an annual salary of over $500,000 and the Vice President of Development made over $400,000 in just one half of a year...
"The Komen Foundation owns stock in General Electric, one of the largest makers of mammogram machines in the world. It also owns stock in several pharmaceutical companies, including AstraZeneca (now AzkoNobel).
AstraZeneca has long been a Komen booster, making educational grants to Komen and having a visible presence at the Race For the Cure. At the 1998 Food and Drug Administration hearings, the Komen Foundation was the only national breast cancer group to endorse the AstraZeneca cancer treatment drug tamoxifen as a prevention device for healthy but high-risk women, despite vehement opposition by most other breast cancer groups because of its links to uterine cancer.
The organization’s biggest sponsors are — surprise! — the corporations that profit from cancer through chemotherapy and radiation. To them, Komen for the Cure isn’t really about finding a cure for cancer; it’s about promoting cancer so that they can sell more drugs and radiotherapy that keeps more patients locked into a cycle of dependence on toxic cancer treatments."
"Komen receives over $55 million in annual revenue from corporate sponsorships, from such health-minded companies as Coca Cola, General Mills, and KFC — that’s right, the fast-food joint contributing to American society with buckets of diseased and tortured birds fried in genetically modified toxins. Buy a bucket of junk food, and pretend as though you’re helping to save lives while you slowly take your own!"
"Did you know that Susan G. Komen for the Cure spends nearly a million dollars annually suing small charities over the use of the word 'cure' in their charitable endeavors? Komen’s general counsel, Jonathan Blum, had the following to say regarding a legal battle of Komen's that threatened to shut down a small lung cancer organization for using the word “cure” in its name: 'We see it as responsible stewardship of our donor’s funds.'"